Target intelligence / Profile preview

Biological tissue surfaces and lymphatic structures

Molecular classification
Other
01

Overview

Biological tissue surfaces and lymphatic structures refer to the anatomical interfaces and the specialized drainage system responsible for maintaining fluid homeostasis and facilitating immune responses (StatPearls, 2023). The lymphatic system consists of a network of vessels, lymph nodes, and lymphoid tissues that transport lymph—a fluid containing white blood cells, proteins, and lipids—from the interstitial spaces of tissues back into the bloodstream (NIH NCI, 2024). While not a single molecular target like a receptor or enzyme, these structures are critical in the context of oncology, as they serve as primary routes for cancer metastasis. In immunology, they coordinate the body's defense against pathogens by transporting antigens to lymph nodes for immune recognition. Pharmacologically, these structures are often the focus of diagnostic agents such as Technetium Tc 99m sulfur colloid for lymphoscintigraphy and sentinel node mapping (FDA, 2022). Additionally, subcutaneous drug delivery relies on the permeability of these tissue surfaces and the efficiency of lymphatic uptake for systemic absorption. Because the term describes a broad physiological compartment rather than a discrete protein or gene product, it is classified as an anatomical system rather than a conventional therapeutic target.

Other names
Lymphatic systemInterstitial spaceTissue interfacesLymphatic networkLymphatic vessels
02

Mechanism of action

Agents targeting these structures typically utilize interstitial uptake and lymphatic transport to visualize drainage patterns or achieve localized therapeutic effects in lymphoid tissues (PubMed, 2021).

03

Biological functions

Fluid homeostasisImmune surveillanceLipid transportWaste clearanceAntigen presentation
04

Disease associations

Cancer metastasisLymphedemaInflammationInfectionLymphoma
05

Safety considerations

LymphedemaInjection site reactionsHypersensitivity to imaging dyesAltered drug distribution in lymphatic obstruction
06

Interacting drugs

Technetium Tc 99m sulfur colloid

3 more in the full profile.

07

Biomarkers

Podoplanin (D2-40)Lymphatic vessel endothelial hyaluronan receptor 1 (LYVE-1)Vascular endothelial growth factor receptor 3 (VEGFR-3)

Beyond the preview

Go deeper on Biological tissue surfaces and lymphatic structures.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Biological tissue surfaces and lymphatic structures.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call